Clinical trial
Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation
NCT00342966 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 14, 1999
- Completion date
- July 23, 2010
- Enrollment
- 34 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer